
Stemedix, Inc.
30% IV / Systemic Cell Therapy · 25% Mesenchymal Stem Cell (MSC) Therapy · 15% Adipose-Derived Stem Cell Therapy
Starting from
$5,000
Cells sourced from umbilical cord tissue or cord blood.
Ratings updated September 30, 2026. Verification is accreditation-based: see our methodology.
8 clinics

30% IV / Systemic Cell Therapy · 25% Mesenchymal Stem Cell (MSC) Therapy · 15% Adipose-Derived Stem Cell Therapy
Starting from
$5,000
45% Regenerative Orthopedics · 20% Bone-Marrow-Derived Therapy · 15% Adipose-Derived Stem Cell Therapy
Starting from
$25,000
40% Exosome Therapy · 25% Mesenchymal Stem Cell (MSC) Therapy · 20% IV / Systemic Cell Therapy
Pricing on consultation

55% Umbilical Cord / Cord-Blood Therapy · 30% Regenerative Orthopedics · 15% Platelet-Rich Plasma (PRP)
Pricing on consultation

35% Mesenchymal Stem Cell (MSC) Therapy · 30% IV / Systemic Cell Therapy · 20% Umbilical Cord / Cord-Blood Therapy
Pricing on consultation

55% Umbilical Cord / Cord-Blood Therapy · 25% IV / Systemic Cell Therapy · 10% Mesenchymal Stem Cell (MSC) Therapy
Pricing on consultation

30% Regenerative Orthopedics · 25% Platelet-Rich Plasma (PRP) · 20% Mesenchymal Stem Cell (MSC) Therapy
Pricing on consultation

40% Mesenchymal Stem Cell (MSC) Therapy · 20% Exosome Therapy · 15% Platelet-Rich Plasma (PRP)
Pricing on consultation
Umbilical cord stem cell therapy is a regenerative medicine treatment that uses stem cells obtained from donated umbilical cord tissue or cord blood after a healthy birth. These donated tissues are collected with parental consent and are processed under regulated protocols before being used in eligible treatment programs.
Unlike autologous stem cell therapy, which uses a patient's own cells, umbilical cord stem cell therapy uses allogeneic stem cells from a donor source. Clinics may offer this treatment for a range of orthopedic, neurological, autoimmune, and inflammatory conditions, depending on local regulations and physician recommendations.
Treatment protocols vary between clinics, making it important to compare physician expertise, laboratory standards, and patient evaluation before selecting a provider.
An umbilical cord stem cell injection delivers stem cell-based biologic products to the area being treated as part of a physician-directed regenerative medicine protocol. Depending on the patient's condition and treatment plan, injections may be used for joints, soft tissues, or other targeted areas.
Before treatment, patients typically undergo a medical evaluation to determine whether they are suitable candidates. The number of injections, treatment schedule, and follow-up care depend on the clinic's protocol and the condition being addressed.
Because treatment methods differ between providers, patients should ask how the cells are processed, how the procedure is performed, and what follow-up care is included.
Not all regenerative medicine clinics follow the same treatment protocols. When comparing providers, consider:
Physician qualifications and regenerative medicine experience
Source of the donated umbilical cord tissue or cord blood
Donor screening and laboratory quality standards
Individualized treatment planning
Follow-up care and patient monitoring
Transparent discussion of expected benefits, limitations, and risks
Reviewing these factors can help patients compare clinics beyond location or advertised treatment claims.
The cost of umbilical cord stem cell therapy depends on factors such as the condition being treated, treatment protocol, physician expertise, and the number of injections or treatment sessions recommended.
This one is worth being extra clear about, because it is the treatment type most likely to raise regulatory questions if a clinic is not handling it correctly.
Cord blood and umbilical cord tissue are allogeneic. They come from a donor, with consent from the donating family, not from the patient. In the United States, cord-tissue-derived products are regulated more like biological drugs, and the FDA has specifically and repeatedly warned about clinics marketing unapproved cord-tissue products with exaggerated claims. This is one of the more scrutinized corners of the regenerative medicine industry.
That does not mean every cord tissue product is a problem. Some are legitimately manufactured under proper FDA registration, often marketed for their growth-factor and scaffolding properties rather than as a live stem cell product, a distinction some marketing blurs.
It does mean this is the category where pointed questions matter most. Is the product FDA-registered? Does the clinic disclose the manufacturer? Is it being marketed as containing living, functional stem cells, a claim that is harder to substantiate for processed cord tissue than for freshly collected autologous cells? Our methodology page explains what we check before listing a clinic, and our frequently asked questions cover what to ask on a consultation call.
Information only. Not medical advice or an endorsement. Always consult a licensed physician. Individual results vary and no outcome is guaranteed.